No profile data available.
biote Corp. (BTMD) is a healthcare company in the medical practice administration industry, based in Irving, United States, with about 223 full-time employees.
It reported revenue of $197.19 million for fiscal year 2024, up 6.4% from fiscal year 2023, and net income of $3.16 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $47.96 million, down 6.7% from a year before. United States was its largest region in fiscal year 2025, with 99% of revenue. Its market capitalization was $38.98 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
biote reported $197.19 million in revenue for fiscal year 2024, up 6.4% from $185.36 million in fiscal year 2023. In Q3 2025 revenue was $47.96 million.
United States: 99% of revenue by region in fiscal year 2025, followed by ALL Other (1%).
$38.98 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medical practice administration) include P3 Health Partners Inc. (PIII), Evolent Health, Inc. (EVH), agilon health, inc. (AGL), Umc, Inc. (UMCN).